Polyrizon

Polyrizon is a biotech company focused on the development and commercialization of innovative intranasal products.

Health Tech & Life Sciences
public
Public Ra'anana, Israel Founded 2005
Last updated 2026-11-09
Total raised
$32.5M
Last: PIPE 2026-09
Stage
Public
Founded
2005
Headcount
6
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences

About

Polyrizon is a development-stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays. Their proprietary Capture and Contain™ (C&C) hydrogel technology creates a thin shield containment barrier in the nasal cavity to protect against viruses and allergens. They are also developing the Trap & Target™ (T&T) platform for intranasal drug delivery, designed to enhance drug absorption and retention for various pharmaceutical ingredients.

Funding history · 7 rounds · $32.5M total

7 events/rounds · $32.5M Total Funding: $31.8M in Public Equity, $719K in Debt
Sep 2026
Public Offering $3.1M EDGAR filing SEC-EDGAR 424B5
Apr 2026
Public Offering $2.5M EDGAR filing SEC-EDGAR 424B5
Dec 2025
Public Offering $5.0M EDGAR filing SEC-EDGAR 424B5
May 2025
Public Offering $17.0M EDGAR filing SEC-EDGAR 424B3
Oct 2024
Public Offering $4.2M EDGAR filing SEC-EDGAR 424B4
Feb 2023
Convertible Debt Undisclosed sec.gov
★ certain shareholders (2023 Lenders)
Jan 2022
Convertible Debt $719K sec.gov

Acquisitions · 1

Mar 2026

Offices

Ra'anana, Israel · HQ / main office

Q&A

What is Polyrizon's primary focus?
Polyrizon is a biotech company focused on the development and commercialization of innovative intranasal products, including medical device hydrogels for protection against viruses and allergens, and a platform for enhanced intranasal drug delivery.
When was Polyrizon founded and where is its headquarters located?
Polyrizon was founded in January 2005 and is headquartered in Ra'anana, Israel.
What is the total amount of funding Polyrizon has raised to date?
Polyrizon has raised a total of $32,539,406.8 in funding.
What was Polyrizon's most recent funding round?
Polyrizon's most recent funding round was a PIPE round in September 2026, raising $4,000,000.
Did Polyrizon engage in any acquisition activities recently?
Yes, Polyrizon acquired Colugo Systems in March 2026 for $6,000,000.
Who is the CEO of Polyrizon?
Tomer Izraeli is the Chief Executive Officer and Director of Polyrizon.
What is Polyrizon's proprietary technology for protection against viruses and allergens?
Polyrizon utilizes its proprietary Capture and Contain™ (C&C) hydrogel technology to create a thin shield containment barrier in the nasal cavity for protection against viruses and allergens.

Team · 9

Tomer Izraeli
Founder · Chief Executive Officer and Director
LinkedIn ↗
Nir Ben Yosef
Chief Financial Officer
Dr. Tidhar Turgeman
Chief Technology Officer
Dr. Eyal S. Ron
Chief Science Officer
Liron Carmel
Director
Liat Sidi
Independent Director
Yehonatan Zalman Vinokur
Independent Director
Oz Adler
Independent Director
Asaf Itzhaik
Director

Sectors & technology

Primary sector
Health Tech & Life Sciences
Target customers
Business model
B2B2C

Highlights

Patents

Tags

allergybiopharmaceuticalbiotechnologypharmaceuticalsbiomaterialspolymerstopical-treatmentpharma-companiesdrug-deliveryhealth-technology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepolyrizon-biotech.com/
LinkedInlinkedin.com/company/202428

Identifiers & details

Legal namePolyrizon Ltd.
Founded2005-1
Employees (exact)6

Acquisitions & public offerings

AcquiredDateAmount
Colugo Systems2026-03$6.0M

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)513637025
Statusפעילה
Corp typeישראלית חברה ציבורית
Incorporated2005-01-12
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events3 — other (1), people (2)
Registered addressהפנינה 8 רעננה

Recent registry events

DateEvent
2026-01-08עדכון כתובת ו/או מען דיגיטלי
2026-05-04עדכון בעלי תפקידים
2026-06-02עדכון דירקטורים-הוספת דירקטור